Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 75 of 1,261
  1. US 12173289

    Hepatitis B virus (HBV) dsRNA agent compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  2. US 12173089

    Inhibition of pulmonary fibrosis with nutlin-3A and peptides

    The Board of Regents of the University of Texas System · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  3. US 12173086

    Alpha-v beta-6 integrin ligands and uses thereof

    Arrowhead Pharmaceuticals, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  4. US 12171741

    2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  5. US 12171777

    Methods of making a cyclic dinucleotide

    Takeda Pharmaceutical Company Limited · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  6. US 12171760

    Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors

    Corcept Therapeutics Incorporated · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  7. US 12171765

    Combination therapies using PRMT5 inhibitors for the treatment of cancer

    Mirati Therapeutics, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  8. US 12171864

    Biological self-assembled nanocrystal injection having a lymphatic targeting function and preparation method

    SHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL CO., LTD · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  9. US 12172994

    Pyrimidine compound as JAK kinase inhibitor

    Theravance Biopharma R&D IP, LLC · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  10. US 12171734

    Pathogenic bacteria

    Sporegen Limited · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  11. US 12171759

    Methods and uses for treating anhedonia

    Xenon Pharmaceuticals Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  12. US 12171877

    Materials and methods for delivering compositions to selected tissues

    The Regents of the University of California · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  13. US 12171761

    Vilazodone inclusion complexes, compositions and preparation thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  14. US 12173079

    Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

    Dyne Therapeutics, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  15. US 12173021

    Treprostinil prodrugs

    United Therapeutics Corporation · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  16. US 12171822

    Infectious plasmodium sporozoites grown in vitro

    Sanaria Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  17. US 12171803

    Methods of CD40 and toll like receptor immune activation

    The Board of Regents of the University of Texas System · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  18. US 12173337

    Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  19. US 12171854

    Heterocyclic-dithiol click chemistry

    Northwestern University · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  20. US 12173288

    Oligonucleotide-ligand conjugates and process for their preparation

    Alnylam Pharmaceuticals, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  21. IT 202300012522

    FLUOROMETIL-CARNITINA PER USO COME INIBITORE DI COLINA TRIMETILAMMINA (TMA) LIASI.

    ALFASIGMA SPA [IT] · Granted Dec 22, 2024 · Expires Dec 17, 2044

    granted
  22. WO 2024259178

    INHIBITEURS DE GLYCOGÈNE SYNTHASE KINASE 3 ET LEURS UTILISATIONS

    BROAD INST INC [US] · Granted Dec 19, 2024 · Expires Dec 14, 2044

    granted
  23. US 12168648

    Opioid receptor modulators

    EPIODYNE, INC. · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted
  24. US 12168675

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.